|
2017
|
Invention
|
Assays for resistance to echinocandin-class drugs. Nucleic acid amplification assays for mutation... |
|
2014
|
Invention
|
Compositions and methods for treating cancer.
The instant invention provides a method of treatin... |
|
2012
|
Invention
|
Method for detection of amyloid beta oligomers in a fluid sample and uses thereof.
The invention... |
|
2011
|
Invention
|
Uses of macrophage mannose receptor to screen compounds and uses of these compounds.
Methods and... |
|
2010
|
Invention
|
Granulocyte-colony stimulating factor produced in glycoengineered pichia pastoris.
Compositions ... |
|
|
Invention
|
Quinazolinone t-type calcium channel antagonists.
The present invention is directed to quinazoli... |
|
|
Invention
|
Lung cancer treatment. The invention provides a method for treating NSCLC, especially in cases of... |
|
2009
|
Invention
|
Generation and characterization of anti-notch antibodies for therapeutic and diagnostic use.
The... |
|
|
Invention
|
Oxgr1 agonists for use in therapies for metabolic disorders.
Methods for identifying OXGR1 modul... |
|
|
Invention
|
Combination therapy. The invention provides the use of a combination of an mTOR inhibitor chsu as... |
|
|
Invention
|
Methods to evaluate glucocorticoid receptor agonists and antagonists for effects on neuron-like c... |
|
|
Invention
|
3h-imidazo[4,5-b]pyridin-5-ol derivatives useful in the treatment of gpr81 receptor disorders. Th... |
|
|
Invention
|
Sulfonamide derivative metabotropic glutamate r4 ligands. Disclosed are mGluR4 positive all... |
|
|
Invention
|
Compositions and methods of depleting amyloid-beta peptides from cerebrospinal fluid to treat alz... |
|
|
Invention
|
Angiotensin ii receptor antagonists. A compound having the structure (formula 1) wherein R is a "... |
|
|
Invention
|
Methods of using mir210 as a biomarker for hypoxia and as a therapeutic agent for treating cancer... |
|
|
Invention
|
Integrin targeting agents and in-vivo and in-vitro imaging methods using the same. The invention ... |
|
|
Invention
|
Prodrugs of cgrp receptor antagonist. Disclosed are prodrug compounds of formula (I) (wherein var... |
|
|
Invention
|
Pharmaceutically acceptable salts of 2-{4-[(3s)-piperidin-3- yl]phenyl} -2h-indazole-7-carboxamid... |
|
2008
|
Invention
|
Synthesis and crystalline forms of melanocortin-4 receptor agonist.
The present invention relate... |
|
|
Invention
|
Addition of lecithin as an antistatic agent for the crystallization processing of organic molecul... |
|
|
Invention
|
Microdrive and modular microdrive assembly for positioning instruments in animal bodies. Microdri... |
|
|
Invention
|
Cb2 receptor ligands for the treatment of pain.
The present invention relates to compounds repre... |
|
|
Invention
|
Macrocyclic compounds as antiviral agents. A class of macrocyclic compounds offormula (I), wherei... |
|
|
Invention
|
Use of mdck cells in the evaluation of cholesterol modulators.
A novel use for MDCK cells in the... |
|
|
Invention
|
Antidiabetic azaindoles and diazaindoles. Azaindoles and diazaindoles having aromatic substituent... |
|
|
Invention
|
Tricyclic anilide heterocyclic cgrp receptor antagonists. Compounds of formula I: wherein variabl... |
|
|
Invention
|
Carboxamide heterocyclic cgrp receptor antagonists. Compounds of formula I: I wherein variables A... |
|
|
Invention
|
Antigen-binding proteins targeting s. aureus orf0657n. The present invention features antigen bin... |
|
|
Invention
|
Pyridyl piperidine orexin receptor antagonists. The present invention is. directed to pyridyl pip... |
|
|
Invention
|
Cyclopropyl pyrrolidine orexin receptor antagonists. The present invention is directed to cyclopr... |
|
|
Invention
|
Oxo bridged diazepan orexin receptor antagonists. The present invention is directed to oxo bridge... |
|
|
Invention
|
Spiroindalones. The present invention relates to spiroindalone compounds useful as HIF prolyl hyd... |
|
|
Invention
|
Polypeptides for inducing a protective immune response against staphylococcus epidermidis. The pr... |
|
2007
|
Invention
|
Angiotensin ii receptor antagonists.
A compound having the structure (Formula I), wherein R an a... |
|
|
Invention
|
Cross-species and multi-species display systems.
The present invention provides expression vecto... |
|
|
Invention
|
2-(phenyl or heterocyclic)-1h-phenanthro[9,10-d]imidazoles.
The invention encompasses novel comp... |
|
|
Invention
|
3-animopyraolines for treatment of neurodegenerative and psychiatric diseases.
Compounds of the ... |
|
|
Invention
|
Neuromedin u receptor subtype 1 deficient transgenic mice and uses thereof.
Transgenic mice that... |
|
2006
|
Invention
|
Azetidine derivatives as glyt1 inhibitors.
The present invention relates to compounds of formula... |
|
|
Invention
|
Ep4 receptor agonist, compositions and methods thereof.
This invention relates to potent selecti... |
|
|
Invention
|
Fluorescent multiplex hpv pcr assays.
The present invention relates a fluorescent multiplex PCR ... |
|
|
Invention
|
Real-time hpv pcr assays.
The present invention relates a fluorescent multiplex PCR assay for de... |
|
|
Invention
|
Tartaric acid salts of a dipeptidyl peptidase-iv inhibitor.
Tartaric acid salts of (3R)-4-[(3R)-... |
|
2005
|
Invention
|
Fluorinated pyrrolo[2,3-d]pyrimidine nucleosides for the treatment of rna-dependent rna viral inf... |
